Home > Financial Ratios > PIRAMAL PHARMA

PIRAMAL PHARMA
EV/Core EBITDA

    Back to All Ratios
COMMUNITY POLL
for PIRAMAL PHARMA
Please provide your vote to see the results

PIRAMAL PHARMA Last 5 Year EV/Core EBITDA History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
   EV/Core EBITDA(x) 21.4915.4015.663.982.20

What is the latest EV/Core EBITDA ratio of PIRAMAL PHARMA ?

The latest EV/Core EBITDA ratio of PIRAMAL PHARMA is 21.49 based on Mar2025 Consolidated results.
Year EV/Core EBITDA
Mar202521.49
Mar202415.40
Mar202315.66
Mar20223.98
Mar20212.20

How is EV/Core EBITDA of PIRAMAL PHARMA Trending?

Years EV/Core EBITDA % Change
Mar2025 21.49
39.55
Mar2024 15.4
-1.66
Mar2023 15.66
293.47
Mar2022 3.98
80.91
Mar2021 2.2 -

Other Financial Ratios of PIRAMAL PHARMA


Compare EV/Core EBITDA ratio of peers of PIRAMAL PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
PIRAMAL PHARMA ₹26,477.7 Cr 0.1% 5% -12.2% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹382,370.0 Cr 0.7% 0.4% -12.5% Stock Analytics
DIVIS LABORATORIES ₹160,087.0 Cr -1.7% 2% 16.7% Stock Analytics
CIPLA ₹126,308.0 Cr -0.9% 5.3% -3.7% Stock Analytics
TORRENT PHARMACEUTICALS ₹121,614.0 Cr -0.1% 0.6% 6.6% Stock Analytics
DR REDDYS LABORATORIES ₹108,845.0 Cr 4.1% 7.6% -3% Stock Analytics


PIRAMAL PHARMA Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
PIRAMAL PHARMA

0.1%

5%

-12.2%

SENSEX

1.1%

1%

-0.9%


You may also like the below Video Courses